Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion type Assertion NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_head.
- NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion description "[Immunohistochemical detection of expression of the epidermal growth factor receptor (EGFR) has been utilized to identify eligible patients with solid malignant tumors, including colorectal adenocarcinoma, for monoclonal antibody therapy (eg, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_provenance.
- NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion evidence source_evidence_literature NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_provenance.
- NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion SIO_000772 16648870 NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_provenance.
- NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion wasDerivedFrom befree-20140225 NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_provenance.
- NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion wasGeneratedBy ECO_0000203 NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_provenance.